Argenx Se (ARGX) Gross Profit Margin starting from the fourth quarter 2025 to fourth quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Argenx Se  (NASDAQ: ARGX)


Argenx Se's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARGX Gross Profit Margin (Dec 31 2025)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Dec 31 2024)
Q4
Y / Y Revenue Change 89.08 %
Seq. Revenue Change -
Revenue In Millions $8,399.37
Gross Profit Margin 94.63 %
Gross Profit Margin Total Ranking # 237
Gross Profit In Millions $7,948.70
Y / Y Gross Profit Change 88.58 %
Seq. Gross Profit Change -


Commenting fourth quarter 2025 Gross Profit Margin



Observing fourth quarter 2025 results within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 237.
Learn about Gross Margin
ARGX's Gross Profit Margin fourth quarter 2025 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 31
Overall # 236

Gross Profit Margin Statistics
High Average Low
96.56 % 95.34 % 94.63 %
(Dec 31 2022)   (Dec 31 2025)


ARGX Gross Income Trends • More of ARGX's Profitabilty Ratios • ARGX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ARGX's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ARGX's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ARGX's Competitors
Gross Profit Margin Profit Margin for Argenx Se's Suppliers
Gross Profit Margin Profit Margin for ARGX's Customers

You may also want to know
ARGX's Annual Growth Rates ARGX's Profitability Ratios ARGX's Asset Turnover Ratio ARGX's Dividend Growth
ARGX's Roe ARGX's Valuation Ratios ARGX's Financial Strength Ratios ARGX's Gross Profit Growth
ARGX's Roa ARGX's Inventory Turnover Ratio ARGX's Growth Rates ARGX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2025, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2025 MRQ Gross ProfitDec 31 2025 MRQ Revenue
Vir Biotechnology Inc   99.98 %$ 64.055  Millions$ 64.070  Millions
Lineage Cell Therapeutics Inc   99.46 %$ 6.572  Millions$ 6.608  Millions
Immunitybio inc   99.00 %$ 37.903  Millions$ 38.285  Millions
Neurocrine Biosciences Inc   97.82 %$ 787.900  Millions$ 805.500  Millions
Biocryst Pharmaceuticals Inc   97.66 %$ 397.033  Millions$ 406.555  Millions
Immunocore Holdings Plc  97.41 %$ 101.775  Millions$ 104.478  Millions
Exelixis Inc   95.58 %$ 572.182  Millions$ 598.663  Millions
Argenx Se  94.63 %$ 7,948.701  Millions$ 8,399.366  Millions
Tarsus Pharmaceuticals Inc   90.82 %$ 137.746  Millions$ 151.668  Millions
Compugen Ltd  87.29 %$ 63.513  Millions$ 72.764  Millions
X4 Pharmaceuticals Inc  85.83 %$ 2.204  Millions$ 2.568  Millions
Novavax inc   84.98 %$ 125.035  Millions$ 147.139  Millions
Halozyme Therapeutics Inc   82.56 %$ 372.997  Millions$ 451.767  Millions
Ginkgo Bioworks Holdings Inc   82.20 %$ 27.451  Millions$ 33.396  Millions
Pelthos Therapeutics Inc   82.19 %$ 7.717  Millions$ 9.389  Millions
Zeo Scientifix Inc   80.57 %$ 1.165  Millions$ 1.446  Millions
Gilead Sciences Inc   79.51 %$ 6,301.000  Millions$ 7,925.000  Millions
Vericel Corporation  78.70 %$ 73.128  Millions$ 92.918  Millions
Biogen Inc   78.26 %$ 1,783.900  Millions$ 2,279.400  Millions
Biontech Se  77.64 %$ 2,495.472  Millions$ 3,214.288  Millions
Adaptive Biotechnologies Corporation  74.58 %$ 53.457  Millions$ 71.681  Millions
Lenz Therapeutics Inc   73.68 %$ 1.170  Millions$ 1.588  Millions
Amgen Inc   69.84 %$ 6,890.000  Millions$ 9,866.000  Millions
Coherus Oncology inc   68.27 %$ 8.703  Millions$ 12.748  Millions
Iovance Biotherapeutics inc   67.38 %$ 58.469  Millions$ 86.771  Millions
Creative Medical Technology Holdings Inc   66.87 %$ 0.002  Millions$ 0.003  Millions
Bio techne Corp  64.78 %$ 191.277  Millions$ 295.277  Millions
Qiagen N v   63.87 %$ 1,299.495  Millions$ 2,034.495  Millions
Adma Biologics Inc   63.82 %$ 88.816  Millions$ 139.163  Millions
Alvotech  60.00 %$ 353.346  Millions$ 588.904  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.